| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $2,278,632 ) |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R03DK142029 | Identification of isoform-specific WT1 interaction partners | 000 | 3 | NIH | 12/15/2025 | $118,500 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 00 | 7 | CMS | 12/19/2025 | $1,693,160 |
| | 2026 | 2026 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE031756 | Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis | 000 | 4 | NIH | 12/4/2025 | $375,453 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 03 | 6 | CMS | 12/2/2025 | $0 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01CA298763 | Targeting mutant-MYOD1 driven rhabdomyosarcoma | 000 | 1 | NIH | 12/17/2025 | $0 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01FD008167 | Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma | 000 | 1 | FDA | 12/15/2025 | $0 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01FD008167 | Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma | 000 | 1 | FDA | 12/15/2025 | $0 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 000 | 5 | NIH | 11/4/2025 | $0 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | P50MH127476 | The Center for Accelerating Suicide Prevention in Real-world Settings (ASPIRES) | 000 | 4 | NIH | 12/10/2025 | $0 |
| | 2026 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31CA278353 | Mechanisms of Synergy between Oncolytic Herpes Simplex Virus and Trabectedin in Pediatric Bone Sarcomas | 000 | 3 | NIH | 11/21/2025 | -$19,168 |
| | 2026 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UG3OD035536 | Environmental Influences on Child Health Outcomes (ECHO) and Pregnancy in Ohio | 000 | 2 | NIH | 11/18/2025 | $0 |
| | 2026 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R25HL168795 | Research Experiences in Childhood Heart, Lung, and Blood Science - REaCH LABS | 000 | 2 | NIH | 12/30/2025 | -$38,142 |
| | 2026 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MH123746 | THE IMPACT OF PUBERTAL SUPPRESSION ON ADOLESCENT NEURAL AND MENTAL HEALTH TRAJECTORIES - Resubmission - 1 | 001 | 4 | NIH | 12/23/2025 | $157,087 |
| | 2026 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MH123746 | THE IMPACT OF PUBERTAL SUPPRESSION ON ADOLESCENT NEURAL AND MENTAL HEALTH TRAJECTORIES - Resubmission - 1 | 000 | 4 | NIH | 12/12/2025 | $0 |
| | 2026 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DK125469 | Novel roles for urothelium during urinary tract obstruction | 000 | 5 | NIH | 1/7/2026 | $0 |
| | 2026 | 2023 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE027091 | Forward genetic analysis of congenital craniofacial malformations | 000 | 5 | NIH | 1/6/2026 | -$8,258 |
|
| Issue Date FY: 2025 ( Subtotal = $77,442,014 ) (Continued on the next page) |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 001 | 3 | NIH | 3/14/2025 | $547,566 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | P50MH127476 | The Center for Accelerating Suicide Prevention in Real-world Settings (ASPIRES) | 000 | 4 | NIH | 9/17/2025 | $2,794,170 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H79SM084968 | Expanding Access to Peritrauma and Trauma Treatment for Families in Central Ohio | 001 | 5 | SAMHSA | 9/15/2025 | $399,999 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 03 | 2 | HRSA | 9/12/2025 | $0 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 02 | 2 | HRSA | 8/21/2025 | $218,278 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 01 | 2 | HRSA | 7/24/2025 | $290,476 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H4953004 | Healthy Start Initiative | 00 | 2 | HRSA | 3/27/2025 | $419,629 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23HL159312 | The Development and Evaluation of Visual Communication Tools to Convey Parental and Intergenerational Cardiovascular Disease Risk and Evoke Lifestyle Behavior Change in Low-income Black Families | 000 | 4 | NIH | 8/28/2025 | $157,920 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes and Rectify Historical Structural Racism: The TIME Study | 000 | 4 | NIH | 4/3/2025 | $100,000 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD109000 | Targeted Investment and Meaningful Engagement to Improve MCH Outcomes and Rectify Historical Structural Racism: The TIME Study | 000 | 4 | NIH | 4/3/2025 | $523,063 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 00 | 14 | HRSA | 4/28/2025 | $113,334 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 02 | 14 | HRSA | 8/18/2025 | $226,156 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H7624736 | Ryan White Part C Outpatient EIS Program | 01 | 14 | HRSA | 7/1/2025 | $113,334 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08NS119878 | Reversal of Immunoparalysis Following Traumatic Brain Injury and Systemic Hemorrhage in a Juvenile Rat Model | 000 | 4 | NIH | 4/9/2025 | $187,635 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MD016064 | Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation | 001 | 4 | NIH | 4/1/2025 | $36,548 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MD016064 | Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation | 000 | 4 | NIH | 1/9/2025 | $328,941 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K01DK126991 | Defining the renal urothelium progenitor and its regulation during development and repair | 000 | 5 | NIH | 6/18/2025 | $145,295 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL179812 | Novel pathogenesis of LVNC | 001 | 1 | NIH | 4/22/2025 | $8,646 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL179812 | Novel pathogenesis of LVNC | 000 | 1 | NIH | 4/21/2025 | $674,402 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K23AR078337 | Resilience Factors, Pain, and Physical Activity in Adolescent Chronic Musculoskeletal Pain | 000 | 6 | NIH | 8/29/2025 | $159,581 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD102439 | Randomized trial on mobile technology to reduce young drivers’ cellphone use | 000 | 5 | NIH | 5/21/2025 | $439,259 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DE030065 | Health and Psychosocial Outcomes in Young Children with Cleft Palate | 000 | 5 | NIH | 7/28/2025 | $638,862 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AR078395 | CRISPR-Cas13 gene therapy and RNA editing for Facioscapulohumeral muscular dystrophy (FSHD) | 000 | 5 | NIH | 7/24/2025 | $501,784 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 001 | 5 | NIH | 2/28/2025 | $621,816 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 002 | 5 | NIH | 5/22/2025 | $69,091 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA241554 | Dysregulated transcription processes in Ewing sarcoma | 000 | 6 | NIH | 8/25/2025 | $291,262 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 001 | 5 | NIH | 1/22/2025 | $385,000 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DA052580 | Evaluating the impact of fentanyl test strip use among rural and urban populations | 000 | 5 | NIH | 4/23/2025 | $655,655 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA272872 | Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets | 002 | 4 | NIH | 9/10/2025 | $71,772 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA272872 | Understanding Infantile Rhabdomyosarcoma Biology and Therapeutic Targets | 001 | 4 | NIH | 9/8/2025 | $382,872 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U24CA254445 | (EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank | 000 | 6 | NIH | 7/11/2025 | $2,532,378 |
| | 2025 | 2025 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21MH136554 | Characterizing the role of sleep brain dynamics in the emergence of depression in adolescents | 001 | 1 | NIH | 7/2/2025 | $2,500 |
|
